Extended Data Table 3.
Lorlatinib + chemotherapy in <18 years (cohort B2)
Treatment-related AEs in at least 10% of patients. Each patient reported once as maximum grade in any course, with attribution possibly, probably and definitely.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.